India's only end-to-end integrated dental products maker - crowns/bridges, clear aligners, scanners and paediatric crowns.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 0 | 0 | 0 | 0 | 0 | 11 | 11 | 11 |
| Reserves | 37 | 33 | 9 | 6 | 31 | 198 | 218 | 232 |
| Borrowings | 37 | 39 | 50 | 50 | 61 | 20 | 9 | 13 |
| Other Liabilities | 31 | 34 | 43 | 40 | 46 | 60 | 28 | 38 |
| Total Liabilities | 106 | 106 | 103 | 97 | 139 | 288 | 266 | 294 |
| AssetsFixed Assets | 39 | 42 | 40 | 40 | 46 | 51 | 51 | 63 |
| CWIP | 0 | 7 | 0 | 0 | 0 | 0 | 2 | 0 |
| Investments | 0 | 0 | 0 | 0 | 6 | 10 | 15 | 27 |
| Other Assets | 66 | 56 | 63 | 56 | 87 | 227 | 199 | 204 |
| Total Assets | 106 | 106 | 103 | 97 | 139 | 288 | 266 | 294 |
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 12 | 10 | -2 | 14 | 8 | 44 | -5 |
| Cash from Investing | -18 | -9 | 3 | -10 | -11 | -29 | -80 |
| Cash from Financing | 6 | 0 | -4 | -1 | -3 | 111 | -18 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — |
| Free Cash Flow | -5 | 0 | 0 | 5 | -5 | 28 | -23 |
| FCF Margin | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (64.6×) and current (42.5×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 5.5% growth and a 42× exit, ₹224 only delivers your return if you pay ₹122. The price is currently baking in 18% growth.
EPS grows 5.5%/yr for 5 years, then fades to 6% over 2, exits at 42×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 5.5% | 5.56 |
| FY28 | 5.5% | 5.87 |
| FY29 | 5.5% | 6.19 |
| FY30 | 5.5% | 6.53 |
| FY31 | 5.5% | 6.89 |
| FY32 | 5.8% ·fade | 7.28 |
| FY33 | 6.0% ·fade | 7.72 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.